I read a story of a report years ago of this being an issue in uk, which I think the following graph demonstrates the age bias around that 70 number. One good thing, I don't see an oncologist having to question whether or not an older patient would survive leronlimab treatment

Quote:

---

One UK study of 101 oncologists found that 81% would prescribe chemotherapy for a high risk breast cancer patient aged 68; however only 47% would recommend the same treatment for an otherwise identical patient aged 73xvi. Older people are less likely to have radiotherapy too

---

https://www.macmillan.org.uk/documents/getinv...upport.pdf